Board Reaffirms Unanimous Support for the Hearst Merger and the Certain and Significant Cash Premium It Will Deliver for ShareholdersDALLAS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company” or “DallasNews”), the holding company of The Dallas Morning News and Medium Giant, announced today that its Board of Directors (the “Board”), following consultation with the Company’s legal and financial advisors, reviewed and rejected the revised, non-binding proposal (the “Revised ...

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Consolidated Lithium Metals Inc. (TSXV: CLM | FRA: Z36) (“CLM” or the “Company”) is pleased to announce that it has entered into a non-binding letter of intent (“LOI”) effective July 31, 2025, with SOQUEM Inc. (“SOQUEM”), a wholly owned subsidiary of Investissement Québec, pursuant to which (subject to completion of several conditions precedent) the Company may acquire an option to earn up to an 80% interest in the Kwyjibo Rare Earth Project (the “Project”), locate ...

WINSTON-SALEM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney” or the “Company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD), today announced that senior members of the management team will be participating in the following two upcoming healthcare conferences in September: Citi Biopharma Back to School Conference (Boston)Date:Wednesday, September 3, 2025Time:10:30am ETFormat:Fireside ChatWebcast:Link Morgan Stanley ...

TORONTO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Pasinex Resources Limited (CSE: PSE) (FSE: PNX) ("Pasinex" or the "Company") today announced financial results for the second quarter ended June 30, 2025. The financial statements, management’s discussion and analysis (MD&A), and related certifications are available on SEDAR+. Highlights Three Months Ended Six Months Ended June 30, June 30, <td style="max-width:1%; width:1%; min-width:1%;;vertical-align: b ...

COLUMBUS, Ohio, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bread Financial® Holdings, Inc. (NYSE: BFH) (“Bread Financial” or the “Company”) today announced that its Board of Directors (the “Board”) has authorized a new plan to repurchase up to $200 million of shares of its common stock. There is no expiration date for the repurchase plan. “We are pleased with the progress we have made to strengthen our company. Bread Financial is well-positioned to execute against our capital priorities to grow responsibly, maintain ...

Comprehensive Data-Driven Report Identifies Top Five Trends Shaping the Nearly $150 Billion U.S. Snacking Market CHICAGO, Aug. 27, 2025 /PRNewswire/ -- Conagra Brands, Inc. (NYSE: CAG), a leading maker of iconic snacks including Slim Jim® meat snacks, Orville Redenbacher's® popcorn, DAVID® Seeds, Angie's BOOMCHICKAPOP® popcorn, and Snack Pack® desserts, released today its inaugural Future of Snacking 2025 report. Leveraging Conagra's cutting edge demand science and insights expertise, in partnership with Ci ...

Battle Born Batteries® to serve as the standard lithium power solution in Awaken RV’s debut lineupAwaken RV, a brand-new manufacturer founded by industry veteran, Scott Hubble, debuts its first lineup with Battle Born Batteries® as standard equipmentDragonfly Energy’s Battle Born Batteries® continue to be widely adopted by top RV OEMs, growing the Company’s share of the RV marketThe partnership delivers safe, reliable, and long-lasting lithium power to support modern off-grid RV travel RENO, Nev., Aug. 27, ...

VONORE, Tenn., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MasterCraft Boat Holdings, Inc. (NASDAQ: MCFT) today announced financial results for its fiscal 2025 fourth quarter and year ended June 30, 2025. The overview, commentary, and results provided herein relate to our continuing operations, which consists of our MasterCraft and Pontoon segments. Fourth Quarter Overview: Net sales for the fourth quarter were $79.5 million, up $25.2 million, or 46.4%, from the comparable prior-year periodIncome from continuing oper ...

Figure 1 NANO Nuclear Energy Corporate Representatives with Dioxitek S.A. Directors, including the Company’s General Manager Federico Ramos Napoli New York, N.Y., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NANO Nuclear Energy Inc. (NASDAQ: NNE) (“NANO Nuclear” or “the Company”), a leading advanced nuclear energy and technology company focused on developing clean energy solutions, today announced that it has signed a Memorandum of Understanding (MOU) with Dioxitek S.A, an Argentinian nuclear fuel cycle and urani ...

Company Overview - Minovia Therapeutics Ltd. is a clinical-stage biotechnology company focused on developing therapies for mitochondrial diseases and age-related decline [1][5] - The company is working on its main drug product, MNV-201, which is currently being tested for Pearson Syndrome and Myelodysplastic Syndrome [5] Recent Developments - Minovia has been awarded a $350,000 grant from Countdown for a Cure to develop novel mitochondrial blood-based biomarkers [1][2] - The grant will fund clinical operations for blood sample collection from approximately 30 patients with primary mitochondrial diseases and 140 samples from healthy controls [2] Research and Development - The company aims to develop blood-based functional mitochondrial biomarkers to identify patients who may benefit from its proprietary mitochondrial augmentation technology (MAT) [2] - A clinical trial has been initiated at Sheba Medical Center to collect blood samples for analysis and to determine a "MitoScore" for each sample [2] Market Need - Mitochondrial dysfunction is associated with rare genetic mitochondrial diseases and chronic age-related diseases, with a significant unmet need for effective treatments [3] - Currently, there are no approved therapies for mitochondrial dysfunction, nor functional tests to diagnose and quantify it [3] Business Combination - Minovia has entered into a definitive business combination agreement with Launch One Acquisition Corp., a publicly traded special purpose acquisition company [4] - The transaction is expected to close in late 2025, after which the combined company will operate as Minovia Therapeutics and trade on Nasdaq under a new ticker symbol [4]